IPO - Zhengye Biotechnology Holding Ltd

Form Type: 424B4

Filing Date: 2025-01-07

Corporate Action: Ipo

Type: New

Accession Number: 000121390025001670

Filing Summary: Zhengye Biotechnology Holding Limited is conducting an initial public offering (IPO) of 1,500,000 ordinary shares at an initial price of $4.00 per share. The offering is on a firm commitment basis with Kingswood Capital Partners, LLC as the underwriter. The ordinary shares being offered represent shares of the Cayman Islands holding company rather than the operating entity in China, which introduces certain legal and operational risks tied to their structure. These risks include potential regulatory issues from the People's Republic of China (PRC) regarding cybersecurity and anti-monopoly laws, which could materially affect their ability to operate and raise funds internationally. The company has noted a high degree of risk involved in investing in its shares, as highlighted in the risk factors section of the prospectus. The shares will be listed on NASDAQ, and approval has already been received for this listing. The company aims to utilize the proceeds for business expansion and has no plans for cash dividends in the near future, as it intends to reinvest its earnings.

Document Link: View Document